BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kenny RG, Marmion CJ. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens? Chem Rev 2019;119:1058-137. [PMID: 30640441 DOI: 10.1021/acs.chemrev.8b00271] [Cited by in Crossref: 309] [Cited by in F6Publishing: 321] [Article Influence: 77.3] [Reference Citation Analysis]
Number Citing Articles
1 D'Errico S, Falanga AP, Greco F, Piccialli G, Oliviero G, Borbone N. State of art in the chemistry of nucleoside-based Pt(II) complexes. Bioorg Chem 2023;131:106325. [PMID: 36577221 DOI: 10.1016/j.bioorg.2022.106325] [Reference Citation Analysis]
2 Vaidya SP, Patra M. Platinum glycoconjugates: "Sweet bullets" for targeted cancer therapy? Curr Opin Chem Biol 2023;72:102236. [PMID: 36516491 DOI: 10.1016/j.cbpa.2022.102236] [Reference Citation Analysis]
3 Sullivan MP, Adams M, Riisom M, Herbert CD, Tong KKH, Astin JW, Jamieson SMF, Hanif M, Goldstone DC, Hartinger CG. Platinum(terpyridine) complexes with N-heterocyclic carbene co-ligands: high antiproliferative activity and low toxicity in vivo. Dalton Trans 2023;52:1388-92. [PMID: 36637059 DOI: 10.1039/d2dt02539f] [Reference Citation Analysis]
4 Kacsir I, Sipos A, Kiss T, Major E, Bajusz N, Tóth E, Buglyó P, Somsák L, Kardos G, Bai P, Bokor É. Half sandwich-type osmium, ruthenium, iridium and rhodium complexes with bidentate glycosyl heterocyclic ligands induce cytostasis in platinum-resistant ovarian cancer cells and bacteriostasis in Gram-positive multiresistant bacteria. Front Chem 2023;11. [DOI: 10.3389/fchem.2023.1086267] [Reference Citation Analysis]
5 Yusoh NA, Chia SL, Saad N, Ahmad H, Gill MR. Synergy of ruthenium metallo-intercalator, [Ru(dppz)(2)(PIP)](2+), with PARP inhibitor Olaparib in non-small cell lung cancer cells. Sci Rep 2023;13:1456. [PMID: 36702871 DOI: 10.1038/s41598-023-28454-x] [Reference Citation Analysis]
6 Glykofridi P, Tziouri VE, Xanthopoulos K, Vlachou ME, Correia S, Fischer AL, Thüne K, Hatzidimitriou A, Zerr I, Schmitz M, Sklaviadis T, Hadjipavlou-Litina D, Papagiannopoulou D. Synthesis, structural characterization and study of antioxidant and anti-PrP(Sc) properties of flavonoids and their rhenium(I)-tricarbonyl complexes. J Biol Inorg Chem 2023. [PMID: 36695886 DOI: 10.1007/s00775-022-01986-9] [Reference Citation Analysis]
7 Hou Z, Vanecek AS, Tepe JJ, Odom AL. Synthesis, structure, properties, and cytotoxicity of a (quinoline)RuCp(+) complex. Dalton Trans 2023;52:721-30. [PMID: 36562335 DOI: 10.1039/d2dt03484k] [Reference Citation Analysis]
8 Holzer I, Desiatkina O, Anghel N, Johns SK, Boubaker G, Hemphill A, Furrer J, Păunescu E. Synthesis and Antiparasitic Activity of New Trithiolato-Bridged Dinuclear Ruthenium(II)-arene-carbohydrate Conjugates. Molecules 2023;28. [PMID: 36677958 DOI: 10.3390/molecules28020902] [Reference Citation Analysis]
9 Parveen S, Sur T, Sarkar S, Roy R. Antagonist Impact of Selenium-Based Nanoparticles Against Mycobacterium tuberculosis. Appl Biochem Biotechnol 2023. [PMID: 36637700 DOI: 10.1007/s12010-023-04315-1] [Reference Citation Analysis]
10 Roy A, Chinta JP. Antioxidant conjugated metal complexes and their medicinal applications. Vitam Horm 2023;121:319-53. [PMID: 36707139 DOI: 10.1016/bs.vh.2022.10.003] [Reference Citation Analysis]
11 Babu T, Ghareeb H, Basu U, Schueffl H, Theiner S, Heffeter P, Koellensperger G, Metanis N, Gandin V, Ott I, Schmidt C, Gibson D. Oral Anticancer Heterobimetallic Pt(IV) -Au(I) Complexes Show High In Vivo Activity and Low Toxicity. Angew Chem Int Ed Engl 2023;:e202217233. [PMID: 36628505 DOI: 10.1002/anie.202217233] [Reference Citation Analysis]
12 Campanella B, Braccini S, Bresciani G, De Franco M, Gandin V, Chiellini F, Pratesi A, Pampaloni G, Biancalana L, Marchetti F. The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes. Metallomics 2023;15:mfac096. [PMID: 36515681 DOI: 10.1093/mtomcs/mfac096] [Reference Citation Analysis]
13 Starosta R, Santos TC, Dinis de Sousa AF, Santos MS, Corvo ML, Tomaz AI, de Almeida RFM. Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds. Front Mol Biosci 2022;9:1059116. [PMID: 36660430 DOI: 10.3389/fmolb.2022.1059116] [Reference Citation Analysis]
14 Jiang S, Zhu F, Lin Y, Ran L, Lin F, Tian H, Hu T, Wang P, Lu C. Photothermal-Augmented Reactive Oxygen Species Oxidative Synergistic Therapy Based on Nanoceria Doped Mesoporous Polydopamine Nanoplatform. Materials & Design 2023. [DOI: 10.1016/j.matdes.2023.111590] [Reference Citation Analysis]
15 Marotta C, Giorgi E, Binacchi F, Cirri D, Gabbiani C, Pratesi A. An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies. Inorganica Chimica Acta 2023. [DOI: 10.1016/j.ica.2023.121388] [Reference Citation Analysis]
16 Tomás H, Rodrigues J. Dendrimers and dendrimer-based nano-objects for oncology applications. New Trends in Smart Nanostructured Biomaterials in Health Sciences 2023. [DOI: 10.1016/b978-0-323-85671-3.00002-6] [Reference Citation Analysis]
17 Gabano E, Zanellato I, Pinton G, Moro L, Ravera M, Osella D. The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH(3)COO)Cl(2)(NH(3))(2)(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake. Bioinorg Chem Appl 2022;2022:3698391. [PMID: 36620349 DOI: 10.1155/2022/3698391] [Reference Citation Analysis]
18 Eichhorn T, Kolbe F, Mišić S, Dimić D, Morgan I, Saoud M, Milenković D, Marković Z, Rüffer T, Dimitrić Marković J, Kaluđerović GN. Synthesis, Crystallographic Structure, Theoretical Analysis, Molecular Docking Studies, and Biological Activity Evaluation of Binuclear Ru(II)-1-Naphthylhydrazine Complex. Int J Mol Sci 2022;24. [PMID: 36614131 DOI: 10.3390/ijms24010689] [Reference Citation Analysis]
19 Riaz Z, Lee BYT, Stjärnhage J, Movassaghi S, Söhnel T, Jamieson SMF, Shaheen MA, Hanif M, Hartinger CG. Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines. J Inorg Biochem 2022;241:112115. [PMID: 36731369 DOI: 10.1016/j.jinorgbio.2022.112115] [Reference Citation Analysis]
20 Xiong K, Wei F, Chen Y, Ji L, Chao H. Recent Progress in Photodynamic Immunotherapy with Metal-Based Photosensitizers. Small Methods 2022;:e2201403. [PMID: 36549671 DOI: 10.1002/smtd.202201403] [Reference Citation Analysis]
21 M M, Gadre S, Chhatar S, Chakraborty G, Ahmed N, Patra C, Patra M. Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish. J Med Chem 2022;65:16353-71. [PMID: 36459415 DOI: 10.1021/acs.jmedchem.2c01174] [Reference Citation Analysis]
22 Kumari G, Gupta A, Sah RK, Gautam A, Saini M, Gupta A, Kushawaha AK, Singh S, Sasmal PK. Development of Mitochondria Targeting AIE-Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents. Adv Healthc Mater 2022;:e2202411. [PMID: 36515128 DOI: 10.1002/adhm.202202411] [Reference Citation Analysis]
23 Rivas F, Del Mármol C, Scalese G, Pérez-Díaz L, Machado I, Blacque O, Medeiros A, Comini M, Gambino D. New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum. J Inorg Biochem 2022;237:112016. [PMID: 36244312 DOI: 10.1016/j.jinorgbio.2022.112016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Shutkov IA, Mazur DM, Borisova NE, Milaeva ER, Nazarov AA. Dichloro[N-[(η6-phenyl)methyl]-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8tetrahydronaphthalen-2-yl)vinyl)benzamide](1,3,5-triaza-7-phosphatricyclo [3.3.1.13,7]decane-κP7)ruthenium. Molbank 2022;2022:M1506. [DOI: 10.3390/m1506] [Reference Citation Analysis]
25 Desiatkina O, Mösching M, Anghel N, Boubaker G, Amdouni Y, Hemphill A, Furrer J, Păunescu E. New Nucleic Base-Tethered Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Compounds: Synthesis and Antiparasitic Activity. Molecules 2022;27. [PMID: 36500266 DOI: 10.3390/molecules27238173] [Reference Citation Analysis]
26 Turan N, Akdeniz A. Synthesis, Structural Characterization of Schiff Base Ligands and Their RuII‐p‐Cymene Complexes, and Catalytic Activity in the Transfer Hydrogenation of Ketones. Catal Lett 2022. [DOI: 10.1007/s10562-022-04222-w] [Reference Citation Analysis]
27 Larasati L, Lestari WW, Firdaus M. Dual-Action Pt(IV) Prodrugs and Targeted Delivery in Metal-Organic Frameworks: Overcoming Cisplatin Resistance and Improving Anticancer Activity. BCSJ 2022;95:1561-1577. [DOI: 10.1246/bcsj.20220218] [Reference Citation Analysis]
28 Doroudian M, Gailer J. Integrative Metallomics Studies of Toxic Metal(loid) Substances at the Blood Plasma–Red Blood Cell–Organ/Tumor Nexus. Inorganics 2022;10:200. [DOI: 10.3390/inorganics10110200] [Reference Citation Analysis]
29 Ali A, Pervaiz M, Saeed Z, Younas U, Bashir R, Ullah S, Bukhari SM, Ali F, Jelani S, Rashid A, Adnan A. Synthesis and biological evaluation of 4-dimethylaminobenzaldehyde derivatives of Schiff bases metal complexes: A review. Inorganic Chemistry Communications 2022;145:109903. [DOI: 10.1016/j.inoche.2022.109903] [Reference Citation Analysis]
30 Mansouri F, Ortiz D, Dyson PJ. Competitive binding studies of the nucleosomal histone targeting drug, [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C), with oligonucleotide-peptide mixtures. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.112043] [Reference Citation Analysis]
31 Guo D, Lei JH, Rong D, Zhang T, Zhang B, Tang Z, Shen HM, Deng CX, Qu S. Photocatalytic Pt(IV)-Coordinated Carbon Dots for Precision Tumor Therapy. Adv Sci (Weinh) 2022;9:e2205106. [PMID: 36307905 DOI: 10.1002/advs.202205106] [Reference Citation Analysis]
32 Majid SA, Mir JM, Jan G, Shalla AH. Schiff base complexes, cancer cell lines, and anticancer evaluation: a review. Journal of Coordination Chemistry. [DOI: 10.1080/00958972.2022.2131402] [Reference Citation Analysis]
33 Lucaciu RL, Hangan AC, Sevastre B, Oprean LS. Metallo-Drugs in Cancer Therapy: Past, Present and Future. Molecules 2022;27:6485. [PMID: 36235023 DOI: 10.3390/molecules27196485] [Reference Citation Analysis]
34 Zhang Q, Shao J, Wang J, Gong XJ, Liu WX, Wang S, Zhang Y, Yang S, Zhang QS, Wei JX, Tian JL. Antitumor effects of new glycoconjugated PtII agents dual-targeting GLUT1 and Pgp proteins. Dalton Trans 2022. [PMID: 36178270 DOI: 10.1039/d2dt02455a] [Reference Citation Analysis]
35 Velcheva V, Hegetschweiler K, Momekov G, Ivanova S, Ugrinov A, Morgenstern B, Gencheva G. Platinum(IV) Complexes of the 1,3,5-Triamino Analogue of the Biomolecule Cis-Inositol Designed as Innovative Antineoplastic Drug Candidates. Pharmaceutics 2022;14:2057. [DOI: 10.3390/pharmaceutics14102057] [Reference Citation Analysis]
36 Iacopini D, Vančo J, Di Pietro S, Bordoni V, Zacchini S, Marchetti F, Dvořák Z, Malina T, Biancalana L, Trávníček Z, Di Bussolo V. New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity. Bioorganic Chemistry 2022;126:105901. [DOI: 10.1016/j.bioorg.2022.105901] [Reference Citation Analysis]
37 Culpepper JD, Lee K, Portis W, Swenson DC, Daly SR. Fluorination and hydrolytic stability of water-soluble platinum complexes with a borane-bridged diphosphoramidite ligand. Dalton Trans 2022;51:12895-903. [PMID: 35942906 DOI: 10.1039/d2dt01482c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Cooper SM, Siakalli C, White AJP, Frei A, Miller PW, Long NJ. Synthesis and anti-microbial activity of a new series of bis(diphosphine) rhenium(V) dioxo complexes. Dalton Trans 2022;51:12791-5. [PMID: 35920379 DOI: 10.1039/d2dt02157a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Xiong Z, Jiang M, Zhang M, Qiu Y, Zhang D, Lin X, Lamu Z, Zhuoga G, Zhen J, Li H, Lu X, Wu Z. A novel heterometallic ruthenium-silver complex as potential antitumor agent: Studies on its synthesis, in vitro assays and interactions with biomolecular targets. Eur J Pharm Sci 2022;:106276. [PMID: 35977652 DOI: 10.1016/j.ejps.2022.106276] [Reference Citation Analysis]
40 Scoditti S, Mazzone G, Sanna N, Sicilia E. Computational Exploration of the Synergistic Anticancer Effect of a Multi-Action Ru(II)-Pt(IV) Conjugate. Inorg Chem 2022. [PMID: 35900874 DOI: 10.1021/acs.inorgchem.2c02223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Bíró L, Ozsváth A, Kapitány R, Buglyó P. Pd(II) Binding Strength of a Novel Ambidentate Dipeptide-Hydroxypyridinonate Ligand: A Solution Equilibrium Study. Molecules 2022;27:4667. [DOI: 10.3390/molecules27144667] [Reference Citation Analysis]
42 Kasparkova J, Kostrhunova H, Novohradsky V, Ma L, Zhu G, Milaeva ER, Shtill AA, Vinck R, Gasser G, Brabec V, Nazarov AA. Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug? Metallomics 2022;14:mfac048. [PMID: 35759404 DOI: 10.1093/mtomcs/mfac048] [Reference Citation Analysis]
43 Giusto E, Žárská L, Beirne DF, Rossi A, Bassi G, Ruffini A, Montesi M, Montagner D, Ranc V, Panseri S. Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy. Nanomaterials 2022;12:2372. [DOI: 10.3390/nano12142372] [Reference Citation Analysis]
44 Liu L, Chen J, Wang MM, Huang Y, Qian Y, Xue X, Su Z, Liu HK. The cyclometalated iridium (III) complex based on 9-Anthracenecarboxylic acid as a lysosomal-targeted anticancer agent. J Inorg Biochem 2022;235:111913. [PMID: 35905643 DOI: 10.1016/j.jinorgbio.2022.111913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kanaoujiya R, Meenakshi, Srivastava S, Singh R, Mustafa G. Recent advances and application of ruthenium complexes in tumor malignancy. Materials Today: Proceedings 2022. [DOI: 10.1016/j.matpr.2022.07.098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Manzano CM, Nakahata DH, de Paiva RE. Revisiting metallodrugs for the treatment of skin cancers. Coordination Chemistry Reviews 2022;462:214506. [DOI: 10.1016/j.ccr.2022.214506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Huang J, Ding W, Zhu X, Li B, Zeng F, Wu K, Wu X, Wang F. Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs. Front Chem 2022;10:876410. [PMID: 35755267 DOI: 10.3389/fchem.2022.876410] [Reference Citation Analysis]
48 Barbanente A, Gandin V, Ceresa C, Marzano C, Ditaranto N, Hoeschele JD, Natile G, Arnesano F, Pacifico C, Intini FP, Margiotta N. Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration. IJMS 2022;23:7081. [DOI: 10.3390/ijms23137081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Xiong K, Ouyang C, Liu J, Karges J, Lin X, Chen X, Chen Y, Wan J, Ji L, Chao H. Chiral RuII -PtII Complexes Inducing Telomere Dysfunction against Cisplatin-Resistant Cancer Cells. Angew Chem Int Ed Engl 2022;:e202204866. [PMID: 35736788 DOI: 10.1002/anie.202204866] [Reference Citation Analysis]
50 Teixeira-Guedes C, Brás AR, Teixeira RG, Valente A, Preto A. Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs. Pharmaceutics 2022;14:1293. [PMID: 35745864 DOI: 10.3390/pharmaceutics14061293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hildebrandt J, Häfner N, Görls H, Barth MC, Dürst M, Runnebaum IB, Weigand W. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues. Int J Mol Sci 2022;23:6669. [PMID: 35743112 DOI: 10.3390/ijms23126669] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen Q, Cuello-Garibo JA, Bretin L, Zhang L, Ramu V, Aydar Y, Batsiun Y, Bronkhorst S, Husiev Y, Beztsinna N, Chen L, Zhou XQ, Schmidt C, Ott I, Jager MJ, Brouwer AM, Snaar-Jagalska BE, Bonnet S. Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model. Chem Sci 2022;13:6899-919. [PMID: 35774173 DOI: 10.1039/d2sc01646j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Bakare OO, Gokul A, Fadaka AO, Wu R, Niekerk LA, Barker AM, Keyster M, Klein A. Plant Antimicrobial Peptides (PAMPs): Features, Applications, Production, Expression, and Challenges. Molecules 2022;27:3703. [PMID: 35744828 DOI: 10.3390/molecules27123703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Zięba A, Stępnicki P, Matosiuk D, Kaczor AA. What are the challenges with multi-targeted drug design for complex diseases? Expert Opin Drug Discov 2022;:1-11. [PMID: 35549603 DOI: 10.1080/17460441.2022.2072827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Han W, He W, Song Y, Zhao J, Song Z, Shan Y, Hua W, Sun Y. Multifunctional platinum(IV) complex bearing HDAC inhibitor and biotin moiety exhibits prominent cytotoxicity and tumor-targeting ability. Dalton Trans 2022;51:7343-51. [PMID: 35466968 DOI: 10.1039/d2dt00090c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Shahzad K, Asad M, Asiri AM, Irfan M, Iqbal MA. In-vitro anticancer profile of recent ruthenium complexes against liver cancer. Reviews in Inorganic Chemistry 2022;0. [DOI: 10.1515/revic-2021-0040] [Reference Citation Analysis]
57 Chen L, Wu X, Gilchrist AM, Gale PA. Organoplatinum Compounds as Anion‐Tuneable Uphill Hydroxide Transporters. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202116355] [Reference Citation Analysis]
58 Hildebrandt J, Häfner N, Kritsch D, Görls H, Dürst M, Runnebaum IB, Weigand W. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms. Int J Mol Sci 2022;23:4976. [PMID: 35563367 DOI: 10.3390/ijms23094976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Ferraro MG, Piccolo M, Misso G, Santamaria R, Irace C. Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics. Pharmaceutics 2022;14:954. [DOI: 10.3390/pharmaceutics14050954] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
60 Mojaddami A, Karimi A, Mahdavinia M, Fereidoonnezhad M. Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine. Biometals 2022. [PMID: 35445906 DOI: 10.1007/s10534-022-00392-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Balázs B, Tóth Z, Kacsir I, Sipos A, Buglyó P, Somsák L, Bokor É, Kardos G, Bai P. Targeting Multiresistant Gram-Positive Bacteria by Ruthenium, Osmium, Iridium and Rhodium Half-Sandwich Type Complexes With Bidentate Monosaccharide Ligands. Front Chem 2022;10:868234. [DOI: 10.3389/fchem.2022.868234] [Reference Citation Analysis]
62 Khoury A, Sakoff JA, Gilbert J, Scott KF, Karan S, Gordon CP, Aldrich-wright JR. Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity. Pharmaceutics 2022;14:787. [DOI: 10.3390/pharmaceutics14040787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
63 Mansour AM, Radacki K, Shehab OR. Role of the ancillary ligand in determining the antimicrobial activity of Pd(II) complexes with N^N^N-tridentate Coligand. Polyhedron 2022. [DOI: 10.1016/j.poly.2022.115857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Zhang Z, Yang T, Zhang J, Li W, Li S, Sun H, Liang H, Yang F. Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy. J Med Chem 2022. [PMID: 35324188 DOI: 10.1021/acs.jmedchem.1c01790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Chen L, Wu X, Gilchrist AM, Gale PA. Organoplatinum Compounds as Anion‐Tuneable Uphill Hydroxide Transporters. Angewandte Chemie. [DOI: 10.1002/ange.202116355] [Reference Citation Analysis]
66 Bera A, Gautam S, Raza MK, Pal AK, Kondaiah P, Chakravarty AR. BODIPY-dipicolylamine complexes of platinum(II): X-ray structure, cellular imaging and organelle-specific near-IR light type-II PDT. Dalton Trans 2022;51:3925-36. [PMID: 35170587 DOI: 10.1039/d1dt03200c] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Peña Q, Wang A, Zaremba O, Shi Y, Scheeren HW, Metselaar JM, Kiessling F, Pallares RM, Wuttke S, Lammers T. Metallodrugs in cancer nanomedicine. Chem Soc Rev 2022. [PMID: 35262108 DOI: 10.1039/d1cs00468a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
68 Wang Y, Pigeon P, Li W, Yan J, Dansette PM, Othman M, Mcglinchey MJ, Jaouen G. Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Geyl KK, Baykov SV, Kalinin SA, Bunev AS, Troshina MA, Sharonova TV, Skripkin MY, Kasatkina SO, Presnukhina SI, Shetnev AA, Krasavin MY, Boyarskiy VP. Synthesis, Structure, and Antiproliferative Action of 2-Pyridyl Urea-Based Cu(II) Complexes. Biomedicines 2022;10:461. [DOI: 10.3390/biomedicines10020461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
70 Ravera M, Gabano E, McGlinchey MJ, Osella D. Pt(IV) antitumor prodrugs: dogmas, paradigms, and realities. Dalton Trans 2022;51:2121-34. [PMID: 35015025 DOI: 10.1039/d1dt03886a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
71 Jayawardhana AMDS, Zheng YR. Interactions between mitochondria-damaging platinum(IV) prodrugs and cytochrome c. Dalton Trans 2022;51:2012-8. [PMID: 35029256 DOI: 10.1039/d1dt03875c] [Reference Citation Analysis]
72 Sen S, Won M, Levine MS, Noh Y, Sedgwick AC, Kim JS, Sessler JL, Arambula JF. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future. Chem Soc Rev 2022. [PMID: 35099487 DOI: 10.1039/d1cs00417d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
73 Bíró L, Buglyó P, Farkas E. Diversity in the Interaction of Amino Acid- and Peptide-Based Hydroxamic Acids with Some Platinum Group Metals in Solution. Molecules 2022;27:669. [PMID: 35163937 DOI: 10.3390/molecules27030669] [Reference Citation Analysis]
74 Du Y, Wang H, Zhang T, Wen W, Li Z, Bi M, Liu J. An ESIPT-based fluorescent probe with fast-response for detection of hydrogen sulfide in mitochondria. Spectrochim Acta A Mol Biomol Spectrosc 2022;265:120390. [PMID: 34536889 DOI: 10.1016/j.saa.2021.120390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Nahaei A, Mandegani Z, Chamyani S, Fereidoonnezhad M, Shahsavari HR, Kuznetsov NY, Nabavizadeh SM. Half-Sandwich Cyclometalated RhIII Complexes Bearing Thiolate Ligands: Biomolecular Interactions and In Vitro and In Vivo Evaluations. Inorg Chem 2022. [PMID: 35023727 DOI: 10.1021/acs.inorgchem.1c03218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Kacsir I, Sipos A, Bényei A, Janka E, Buglyó P, Somsák L, Bai P, Bokor É. Reactive Oxygen Species Production Is Responsible for Antineoplastic Activity of Osmium, Ruthenium, Iridium and Rhodium Half-Sandwich Type Complexes with Bidentate Glycosyl Heterocyclic Ligands in Various Cancer Cell Models. Int J Mol Sci 2022;23:813. [PMID: 35054999 DOI: 10.3390/ijms23020813] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
77 Bai X, Ali A, Wang N, Liu Z, Lv Z, Zhang Z, Zhao X, Hao H, Zhang Y, Rahman FU. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies. Eur J Med Chem 2022;227:113920. [PMID: 34742012 DOI: 10.1016/j.ejmech.2021.113920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Vlocskó RB, Apaydın S, Török B, Török M. The multitarget approach as a green tool in medicinal chemistry. Contemporary Chemical Approaches for Green and Sustainable Drugs 2022. [DOI: 10.1016/b978-0-12-822248-5.00016-4] [Reference Citation Analysis]
79 Lu Y, Zhu D, Le Q, Wang Y, Wang W. Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy. Nanoscale 2022. [DOI: 10.1039/d2nr02994d] [Reference Citation Analysis]
80 Deo K, Aldrich-wright J. Metal complexes as chemotherapeutic agents. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering 2022. [DOI: 10.1016/b978-0-12-823144-9.00050-9] [Reference Citation Analysis]
81 Liu C, Li C, Jiang S, Zhang C, Tian Y. pH-responsive hollow Fe–gallic acid coordination polymer for multimodal synergistic-therapy and MRI of cancer. Nanoscale Adv 2021;4:173-81. [DOI: 10.1039/d1na00721a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
82 Sonkar C, Sarkar S, Mukhopadhyay S. Ruthenium( ii )–arene complexes as anti-metastatic agents, and related techniques. RSC Med Chem 2022;13:22-38. [DOI: 10.1039/d1md00220a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
83 Cai D, Chen B, Liu Q, Le X, He L. Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(ii) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids. Dalton Trans 2022. [DOI: 10.1039/d2dt02985e] [Reference Citation Analysis]
84 Hu J, Cao T, Yuan B, Guo Y, Zhang J, Zhao J, Zhao X, Hou H. Benzimidazole-quinoline-based copper complexes: Exploration for their possible antitumor mechanism. Polyhedron 2022;211:115563. [DOI: 10.1016/j.poly.2021.115563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Moynihan E, Bassi G, Ruffini A, Panseri S, Montesi M, Velasco-Torrijos T, Montagner D. Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma. Front Chem 2021;9:795997. [PMID: 34950638 DOI: 10.3389/fchem.2021.795997] [Reference Citation Analysis]
86 Li Z, Wang Q, Li L, Chen Y, Cui J, Liu M, Zhang N, Liu Z, Han J, Wang Z. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response. J Med Chem 2021;64:17920-35. [PMID: 34852203 DOI: 10.1021/acs.jmedchem.1c01236] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
87 Green LPM, Steel TR, Riisom M, Hanif M, Söhnel T, Jamieson SMF, Wright LJ, Crowley JD, Hartinger CG. Synthetic Strategy Towards Heterodimetallic Half-Sandwich Complexes Based on a Symmetric Ditopic Ligand. Front Chem 2021;9:786367. [PMID: 34926406 DOI: 10.3389/fchem.2021.786367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Spisz P, Chylewska A, Królicka A, Ramotowska S, Dąbrowska A, Makowski M. Stimulation of Sulfonamides Antibacterial Drugs Activity as a Result of Complexation with Ru(III): Physicochemical and Biological Study. Int J Mol Sci 2021;22:13482. [PMID: 34948278 DOI: 10.3390/ijms222413482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
89 Shutkov IA, Okulova YN, Tyurin VY, Sokolova EV, Babkov DA, Spasov AA, Gracheva YA, Schmidt C, Kirsanov KI, Shtil AA, Redkozubova OM, Shevtsova EF, Milaeva ER, Ott I, Nazarov AA. Ru(III) Complexes with Lonidamine-Modified Ligands. Int J Mol Sci 2021;22:13468. [PMID: 34948263 DOI: 10.3390/ijms222413468] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Balcerzak M. Noble Metals, Analytical Chemistry of. Encyclopedia of Analytical Chemistry 2021. [DOI: 10.1002/9780470027318.a2411.pub3] [Reference Citation Analysis]
91 Hernández‐ayala LF, Novoa‐ramírez CS, Reina M, Ruiz‐azuara L. Mixed Ru II Complexes Containing Diseleno‐Ligand and α,β‐Diketones Donors with Anticancer Activity. Synthesis, Characterization, Electrochemical and DFT Studies. Eur J Inorg Chem 2021;2021:4856-4867. [DOI: 10.1002/ejic.202100756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Mansour AM. Pd(ii) and Pt(ii) complexes of tridentate ligands with selective toxicity against Cryptococcus neoformans and Candida albicans. RSC Adv 2021;11:39748-57. [PMID: 35494132 DOI: 10.1039/d1ra06559a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Dröge F, Noakes FF, Archer SA, Sreedharan S, Raza A, Robertson CC, MacNeil S, Haycock JW, Carson H, Meijer AJHM, Smythe CGW, Bernardino de la Serna J, Dietzek-Ivanšić B, Thomas JA. A Dinuclear Osmium(II) Complex Near-Infrared Nanoscopy Probe for Nuclear DNA. J Am Chem Soc 2021;143:20442-53. [PMID: 34808044 DOI: 10.1021/jacs.1c10325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Predarska I, Saoud M, Morgan I, Eichhorn T, Kaluđerović GN, Hey-Hawkins E. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line. Dalton Trans 2021. [PMID: 34877948 DOI: 10.1039/d1dt03265h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Chakraborty A, Roy S, Chakraborty MP, Roy SS, Purkait K, Koley TS, Das R, Acharya M, Mukherjee A. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation. Inorg Chem 2021;60:18379-94. [PMID: 34780170 DOI: 10.1021/acs.inorgchem.1c02979] [Reference Citation Analysis]
96 Pragti, Kundu BK, Mukhopadhyay S. Target based chemotherapeutic advancement of ruthenium complexes. Coordination Chemistry Reviews 2021;448:214169. [DOI: 10.1016/j.ccr.2021.214169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
97 Ding Y, Dai Y, Wu M, Li L. Glutathione-mediated nanomedicines for cancer diagnosis and therapy. Chemical Engineering Journal 2021;426:128880. [DOI: 10.1016/j.cej.2021.128880] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
98 Priyanka Dorairaj D, Haribabu J, Chang Y, C. N. Hsu S, Echeverria C, Echeverria J, Karvembu R. Effect of new Pd(II)-aroylthiourea complex on pancreatic cancer cells. Inorganic Chemistry Communications 2021;134:109018. [DOI: 10.1016/j.inoche.2021.109018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 de Oliveira Neto JG, Filho JGS, Bittar EM, Silva LM, de Sousa FF, Domingos HV, Costa-Lotufo LV, Reis AS, Dos Santos AO. Structural, thermal, electronic, vibrational, magnetic, and cytotoxic properties of chloro(glycinato-N,O)(1,10-phenanthroline-N,N')‑copper(II) trihydrate coordination complex. J Inorg Biochem 2022;226:111658. [PMID: 34781206 DOI: 10.1016/j.jinorgbio.2021.111658] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Swaminathan S, Haribabu J, Mohamed Subarkhan MK, Gayathri D, Balakrishnan N, Bhuvanesh N, Echeverria C, Karvembu R. Impact of aliphatic acyl and aromatic thioamide substituents on the anticancer activity of Ru(II)-p-cymene complexes with acylthiourea ligands-in vitro and in vivo studies. Dalton Trans 2021;50:16311-25. [PMID: 34730582 DOI: 10.1039/d1dt02611a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
101 Yougbaré S, Mutalik C, Chung PF, Krisnawati DI, Rinawati F, Irawan H, Kristanto H, Kuo TR. Gold Nanorod-Decorated Metallic MoS2 Nanosheets for Synergistic Photothermal and Photodynamic Antibacterial Therapy. Nanomaterials (Basel) 2021;11:3064. [PMID: 34835828 DOI: 10.3390/nano11113064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
102 Wang Y, Ma D, Sun J, Song C, Huo S. Reduction of an asymmetric Pt(IV) prodrug fac-[Pt(dach)Cl3(OC(=O)CH3)] by biological thiol compounds: kinetic and mechanistic characterizations. Transit Met Chem 2021;46:623-31. [DOI: 10.1007/s11243-021-00480-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Papadia P, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin. Dalton Trans 2021;50:15655-68. [PMID: 34673864 DOI: 10.1039/d1dt02255e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
104 Balsa LM, Rodriguez MR, Parajón-Costa BS, González-Baró AC, Lavecchia MJ, León IE. Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres. ChemMedChem 2021. [PMID: 34750978 DOI: 10.1002/cmdc.202100520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Paul S, Kundu P, Kondaiah P, Chakravarty AR. BODIPY-Ruthenium(II) Bis-Terpyridine Complexes for Cellular Imaging and Type-I/-II Photodynamic Therapy. Inorg Chem 2021;60:16178-93. [PMID: 34672556 DOI: 10.1021/acs.inorgchem.1c01850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
106 Lv W, Cao M, Liu J, Hei Y, Bai J. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia. Acta Biomater 2021;135:617-27. [PMID: 34407474 DOI: 10.1016/j.actbio.2021.08.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
107 Upadhyay A, Kumar Jha R, Batabyal M, Dutta T, Koner AL, Kumar S. Janus -faced oxidant and antioxidant profiles of organo diselenides. Dalton Trans 2021;50:14576-94. [PMID: 34590653 DOI: 10.1039/d1dt01565f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
108 Shao J, Zhang Q, Wei J, Yuchi Z, Cao P, Li SQ, Wang S, Xu JY, Yang S, Zhang Y, Wei JX, Tian JL. Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone Cu(II) and Fe(III) complexes targeting lysosomes: special emphasis on their binding to DNA/BSA. Dalton Trans 2021;50:13387-98. [PMID: 34473154 DOI: 10.1039/d1dt02180j] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
109 Kacsir I, Sipos A, Ujlaki G, Buglyó P, Somsák L, Bai P, Bokor É. Ruthenium Half-Sandwich Type Complexes with Bidentate Monosaccharide Ligands Show Antineoplastic Activity in Ovarian Cancer Cell Models through Reactive Oxygen Species Production. Int J Mol Sci 2021;22:10454. [PMID: 34638791 DOI: 10.3390/ijms221910454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
110 Weng C, Shen L, Teo JW, Lim ZC, Loh BS, Ang WH. Targeted Antibacterial Strategy Based on Reactive Oxygen Species Generated from Dioxygen Reduction Using an Organoruthenium Complex. JACS Au 2021;1:1348-54. [PMID: 34604844 DOI: 10.1021/jacsau.1c00262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Rubio AR, González R, Busto N, Vaquero M, Iglesias AL, Jalón FA, Espino G, Rodríguez AM, García B, Manzano BR. Anticancer Activity of Half-Sandwich Ru, Rh and Ir Complexes with Chrysin Derived Ligands: Strong Effect of the Side Chain in the Ligand and Influence of the Metal. Pharmaceutics 2021;13:1540. [PMID: 34683834 DOI: 10.3390/pharmaceutics13101540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Shen YH, Esper AM, Ghiviriga I, Abboud KA, Schanze KS, Ehm C, Veige AS. SPAAC iClick: progress towards a bioorthogonal reaction in-corporating metal ions. Dalton Trans 2021;50:12681-91. [PMID: 34545891 DOI: 10.1039/d1dt02626g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
113 da Silva MM, Ribeiro GH, de Camargo MS, Ferreira AG, Ribeiro L, Barbosa MIF, Deflon VM, Castelli S, Desideri A, Corrêa RS, Ribeiro AB, Nicolella HD, Ozelin SD, Tavares DC, Batista AA. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo. Inorg Chem 2021;60:14174-89. [PMID: 34477373 DOI: 10.1021/acs.inorgchem.1c01539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
114 Yang J, Fang C, Liu H, Wu M, Tao S, Tan Q, Chen Y, Wang T, Li K, Zhong C, Zhang J. Ternary supramolecular nanocomplexes for superior anticancer efficacy of natural medicines. Nanoscale 2021;13:15085-99. [PMID: 34533154 DOI: 10.1039/d1nr02791c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Yougbaré S, Mutalik C, Okoro G, Lin IH, Krisnawati DI, Jazidie A, Nuh M, Chang CC, Kuo TR. Emerging Trends in Nanomaterials for Antibacterial Applications. Int J Nanomedicine 2021;16:5831-67. [PMID: 34475754 DOI: 10.2147/IJN.S328767] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
116 Xu Z, Wang Z, Deng Z, Zhu G. Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs. Coordination Chemistry Reviews 2021;442:213991. [DOI: 10.1016/j.ccr.2021.213991] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 15.5] [Reference Citation Analysis]
117 Prakash P, Kumari N, Gayathiri E, Selvam K, Ragunathan MG, Chandrasekaran M, Al-Dosary MA, Hatamleh AA, Nadda AK, Kumar M. In Vitro and In Silico Toxicological Properties of Natural Antioxidant Therapeutic Agent Azimatetracantha. LAM. Antioxidants (Basel) 2021;10:1307. [PMID: 34439555 DOI: 10.3390/antiox10081307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Fronik P, Poetsch I, Kastner A, Mendrina T, Hager S, Hohenwallner K, Schueffl H, Herndler-Brandstetter D, Koellensperger G, Rampler E, Kopecka J, Riganti C, Berger W, Keppler BK, Heffeter P, Kowol CR. Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands. J Med Chem 2021;64:12132-51. [PMID: 34403254 DOI: 10.1021/acs.jmedchem.1c00770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
119 Annunziata A, Liberti D, Bedini E, Cucciolito ME, Loreto D, Monti DM, Merlino A, Ruffo F. Square-Planar vs. Trigonal Bipyramidal Geometry in Pt(II) Complexes Containing Triazole-Based Glucose Ligands as Potential Anticancer Agents. Int J Mol Sci 2021;22:8704. [PMID: 34445409 DOI: 10.3390/ijms22168704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
120 Oliveira KM, Peterson EJ, Carroccia MC, Cominetti MR, Deflon VM, Farrell NP, Batista AA, Correa RS. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer. Dalton Trans 2020;49:16193-203. [PMID: 32329497 DOI: 10.1039/d0dt01091j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
121 Wang P, Wang JW, Zhang WH, Bai H, Tang G, Young DJ. In Vitro Anticancer Activity of Nanoformulated Mono- and Di-nuclear Pt Compounds. Chem Asian J 2021. [PMID: 34387027 DOI: 10.1002/asia.202100901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Xiong K, Zhou Y, Karges J, Du K, Shen J, Lin M, Wei F, Kou J, Chen Y, Ji L, Chao H. Autophagy-Dependent Apoptosis Induced by Apoferritin-Cu(II) Nanoparticles in Multidrug-Resistant Colon Cancer Cells. ACS Appl Mater Interfaces 2021;13:38959-68. [PMID: 34379404 DOI: 10.1021/acsami.1c07223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
123 Aminzadeh M, Mansouri-Torshizi H, Aleeshah R, Abdi K, Saeidifar M. A new palladium-based antiproliferative agent: synthesis, characterization, computational calculations, cytotoxicity, and DNA binding properties. Biometals 2021. [PMID: 34363565 DOI: 10.1007/s10534-021-00335-8] [Reference Citation Analysis]
124 Valente A, Podolski-Renić A, Poetsch I, Filipović N, López Ó, Turel I, Heffeter P. Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance. Drug Resist Updat 2021;58:100778. [PMID: 34403910 DOI: 10.1016/j.drup.2021.100778] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
125 Holden L, Burke CS, Cullinane D, Keyes TE. Strategies to promote permeation and vectorization, and reduce cytotoxicity of metal complex luminophores for bioimaging and intracellular sensing. RSC Chem Biol 2021;2:1021-49. [PMID: 34458823 DOI: 10.1039/d1cb00049g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
126 Chatterjee R, Bhattacharya I, Roy S, Purkait K, Koley TS, Gupta A, Mukherjee A. Synthesis, Characterization, and Cytotoxicity of Morpholine-Containing Ruthenium(II) p-Cymene Complexes. Inorg Chem 2021;60:12172-85. [PMID: 34346215 DOI: 10.1021/acs.inorgchem.1c01363] [Reference Citation Analysis]
127 Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? J Med Chem 2021;64:11364-78. [PMID: 34342437 DOI: 10.1021/acs.jmedchem.1c00706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
128 Li Y, Shi S, Zhang S, Gan Z, Wang X, Zhao X, Zhu Y, Cao M, Wang X, Li W. ctc-[Pt(NH3)2(cinnamate)(valproate)Cl2] is a highly potent and low-toxic triple action anticancer prodrug. Dalton Trans 2021;50:11180-8. [PMID: 34338267 DOI: 10.1039/d1dt01421h] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Xian C, Chen H, Xiong F, Fang Y, Huang H, Wu J. Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs. Biomater Sci 2021. [PMID: 34323260 DOI: 10.1039/d1bm00879j] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
130 Wu J, Yang T, Wang X, Li W, Pang M, Sun H, Liang H, Yang F. Development of a multi-target anticancer Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complex. Dalton Trans 2021;50:10909-21. [PMID: 34313274 DOI: 10.1039/d1dt01272j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Gómez J, Sierra D, Ojeda C, Thavalingam S, Miller R, Guzmán F, Metzler-Nolte N. Solid-phase synthesis and evaluation of linear and cyclic ferrocenoyl/ruthenocenoyl water-soluble hexapeptides as potential antibacterial compounds. J Biol Inorg Chem 2021;26:599-615. [PMID: 34292404 DOI: 10.1007/s00775-021-01877-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
132 Rigamonti L, Reginato F, Ferrari E, Pigani L, Gigli L, Demitri N, Kopel P, Tesarova B, Heger Z. From solid state to in vitro anticancer activity of copper(II) compounds with electronically-modulated NNO Schiff base ligands. Dalton Trans 2020;49:14626-39. [PMID: 33057512 DOI: 10.1039/d0dt03038d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
133 Liu J, Ye W, Xu JP, Wang HT, Li XF, Wang WY, Zhou ZZ. Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells. Eur J Med Chem 2021;224:113700. [PMID: 34311158 DOI: 10.1016/j.ejmech.2021.113700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
134 Bai X, Ali A, Lv Z, Wang N, Zhao X, Hao H, Zhang Y, Rahman FU. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways. Eur J Med Chem 2021;224:113689. [PMID: 34293698 DOI: 10.1016/j.ejmech.2021.113689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
135 Geisler H, Westermayr J, Cseh K, Wenisch D, Fuchs V, Harringer S, Plutzar S, Gajic N, Hejl M, Jakupec MA, Marquetand P, Kandioller W. Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies. Inorg Chem 2021;60:9805-19. [PMID: 34115482 DOI: 10.1021/acs.inorgchem.1c01083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
136 Steel TR, Walsh F, Wieczorek-błauż A, Hanif M, Hartinger CG. Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agents. Coordination Chemistry Reviews 2021;439:213890. [DOI: 10.1016/j.ccr.2021.213890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
137 Biancalana L, Kostrhunova H, Batchelor LK, Hadiji M, Degano I, Pampaloni G, Zacchini S, Dyson PJ, Brabec V, Marchetti F. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity. Inorg Chem 2021;60:9529-41. [PMID: 34156246 DOI: 10.1021/acs.inorgchem.1c00641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
138 Ravera M, Gabano E, Perin E, Rangone B, Bonzani D, Osella D. Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? Bioinorg Chem Appl 2021;2021:9489926. [PMID: 34239547 DOI: 10.1155/2021/9489926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Nagy S, Ozsváth A, Bényei AC, Farkas E, Buglyó P. Donor Atom Preference of Organoruthenium and Organorhodium Cations on the Interaction with Novel Ambidentate (N,N) and (O,O) Chelating Ligands in Aqueous Solution. Molecules 2021;26:3586. [PMID: 34208223 DOI: 10.3390/molecules26123586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Gandioso A, Rovira A, Shi H, Sadler PJ, Marchán V. Unexpected photoactivation pathways in a folate-receptor-targeted trans-diazido Pt(IV) anticancer pro-drug. Dalton Trans 2020;49:11828-34. [PMID: 32815971 DOI: 10.1039/d0dt02577a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
141 Păunescu E, Boubaker G, Desiatkina O, Anghel N, Amdouni Y, Hemphill A, Furrer J. The quest of the best - A SAR study of trithiolato-bridged dinuclear Ruthenium(II)-Arene compounds presenting antiparasitic properties. Eur J Med Chem 2021;222:113610. [PMID: 34144354 DOI: 10.1016/j.ejmech.2021.113610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
142 Małecka M, Skoczyńska A, Goodman DM, Hartinger CG, Budzisz E. Biological properties of ruthenium(II)/(III) complexes with flavonoids as ligands. Coordination Chemistry Reviews 2021;436:213849. [DOI: 10.1016/j.ccr.2021.213849] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
143 He M, Chen F, Shao D, Weis P, Wei Z, Sun W. Photoresponsive metallopolymer nanoparticles for cancer theranostics. Biomaterials 2021;275:120915. [PMID: 34102525 DOI: 10.1016/j.biomaterials.2021.120915] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
144 Frei A, Ramu S, Lowe GJ, Dinh H, Semenec L, Elliott AG, Zuegg J, Deckers A, Jung N, Bräse S, Cain AK, Blaskovich MAT. Platinum Cyclooctadiene Complexes with Activity against Gram-positive Bacteria. ChemMedChem 2021. [PMID: 34018686 DOI: 10.1002/cmdc.202100157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
145 Ma YC, Tang XF, Xu YC, Jiang W, Xin YJ, Zhao W, He X, Lu LG, Zhan MX. Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy via DNA damage enhancement. Biomater Sci 2021;9:3401-9. [PMID: 33949448 DOI: 10.1039/d1bm00157d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
146 da Silva AV, Meneghetti SMP, Meneghetti MR. Benzodiazepines: Drugs with Chemical Skeletons Suitable for the Preparation of Metallacycles with Potential Pharmacological Activity. Molecules 2021;26:2796. [PMID: 34068533 DOI: 10.3390/molecules26092796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
147 Swaminathan S, Haribabu J, Kalagatur NK, Nikhil M, Balakrishnan N, Bhuvanesh NSP, Kadirvelu K, Kolandaivel P, Karvembu R. Tunable Anticancer Activity of Furoylthiourea-Based RuII -Arene Complexes and Their Mechanism of Action. Chemistry 2021;27:7418-33. [PMID: 33404126 DOI: 10.1002/chem.202004954] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
148 Jain A, Garrett NT, Malone ZP. Ruthenium-based Photoactive Metalloantibiotics. Photochem Photobiol 2021. [PMID: 33882620 DOI: 10.1111/php.13435] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
149 Bhattacharyya A, Jameei A, Karande AA, Chakravarty AR. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT. Eur J Med Chem 2021;220:113438. [PMID: 33915370 DOI: 10.1016/j.ejmech.2021.113438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
150 Máliková K, Masaryk L, Štarha P. Anticancer Half-Sandwich Rhodium(III) Complexes. Inorganics 2021;9:26. [DOI: 10.3390/inorganics9040026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
151 Silva-Caldeira PP, Oliveira Junior ACA, Pereira-Maia EC. Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands. Molecules 2021;26:2084. [PMID: 33917290 DOI: 10.3390/molecules26072084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Shutkov IA, Antonets AA, Tyurin VY, Milaeva ER, Nazarov AA. Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents. Russ J Inorg Chem 2021;66:502-509. [DOI: 10.1134/s0036023621030177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Karmakar J, Nandy P, Das S, Bhattacharya D, Karmakar P, Bhattacharya S. Utilization of Guanidine-Based Ancillary Ligands in Arene-Ruthenium Complexes for Selective Cytotoxicity. ACS Omega 2021;6:8226-38. [PMID: 33817481 DOI: 10.1021/acsomega.0c06265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
154 Maji M, Acharya S, Bhattacharya I, Gupta A, Mukherjee A. Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p -Cymene Complexes. Inorg Chem 2021;60:4744-54. [DOI: 10.1021/acs.inorgchem.0c03706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
155 Pereira AF, Prandi IG, Ramalho TC. Parameterization and validation of a new force field for Pt( II ) complexes of 2‐(4′‐amino‐2′‐hydroxyphenyl)benzothiazole. Int J of Quantum Chemistry 2021;121. [DOI: 10.1002/qua.26525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
156 Maji M, Bhattacharya I, Acharya S, Chakraborty MP, Gupta A, Mukherjee A. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells. Inorg Chem 2021;60:4342-6. [PMID: 33711231 DOI: 10.1021/acs.inorgchem.0c03803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Miranda VM. Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates. Reviews in Inorganic Chemistry 2021;0:000010151520200030. [DOI: 10.1515/revic-2020-0030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
158 Chellan P, Avery VM, Duffy S, Land KM, Tam CC, Kim JH, Cheng LW, Romero-Canelón I, Sadler PJ. Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin. J Inorg Biochem 2021;219:111408. [PMID: 33826972 DOI: 10.1016/j.jinorgbio.2021.111408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
159 Zhang Q, Wang S, Zhu Y, Zhang C, Cao H, Ma W, Tian X, Wu J, Zhou H, Tian Y. Functional Platinum(II) Complexes with Four-Photon Absorption Activity, Lysosome Specificity, and Precise Cancer Therapy. Inorg Chem 2021;60:2362-71. [PMID: 33494602 DOI: 10.1021/acs.inorgchem.0c03245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
160 Saini B, Singh R, Mukhopadhyay S, Mukherjee TK. Specific Loading and In Vitro Controlled Release of a Ru-Based Hydrophobically Encapsulated Model Anticancer Drug inside Nanoassemblies toward Stimuli-Responsive Drug Delivery. ACS Appl Nano Mater 2021;4:2037-51. [DOI: 10.1021/acsanm.0c03356] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
161 Annunziata A, Cucciolito ME, Esposito R, Traboni S, Tuzi A, Budzelaar PHM, Ruffo F. Oxidative Addition of α‐Glycosyl Halides to a Platinum(0) Olefin Complex: Stereochemistry of Pt−C Bond Formation. Eur J Inorg Chem 2021;2021:534-539. [DOI: 10.1002/ejic.202001088] [Reference Citation Analysis]
162 Acharya S, Maji M, Chakraborty MP, Bhattacharya I, Das R, Gupta A, Mukherjee A. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases. Inorg Chem 2021;60:3418-30. [PMID: 33554592 DOI: 10.1021/acs.inorgchem.0c03820] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
163 Jin S, Guo Y, Guo Z, Wang X. Monofunctional Platinum(II) Anticancer Agents. Pharmaceuticals (Basel) 2021;14:133. [PMID: 33562293 DOI: 10.3390/ph14020133] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
164 Rivas F, Medeiros A, Quiroga C, Benítez D, Comini M, Rodríguez-Arce E, Machado I, Cerecetto H, Gambino D. New Pd-Fe ferrocenyl antiparasitic compounds with bioactive 8-hydroxyquinoline ligands: a comparative study with their Pt-Fe analogues. Dalton Trans 2021;50:1651-65. [PMID: 33449983 DOI: 10.1039/d0dt03963b] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
165 Nawaz H, Abbasi R, Nafees M, Rehman ZU, Ahmad I, Arshad MN, Asiri AM, Waseem A. Structural chemistry and anticancer activity of new heteroleptic palladium(II) carbodithioates. Journal of Molecular Structure 2021;1225:129058. [DOI: 10.1016/j.molstruc.2020.129058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Lovison D, Allegri L, Baldan F, Ballico M, Damante G, Jandl C, Baratta W. Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells. Dalton Trans 2020;49:8375-88. [PMID: 32520028 DOI: 10.1039/d0dt01390k] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
167 Azam M, Mohammad Wabaidur S, Alam M, Trzesowska-kruszynska A, Kruszynski R, Al-resayes SI, Fahhad Alqahtani F, Rizwan Khan M, Rajendra. Design, structural investigations and antimicrobial activity of pyrazole nucleating copper and zinc complexes. Polyhedron 2021;195:114991. [DOI: 10.1016/j.poly.2020.114991] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
168 Guarra F, Pratesi A, Gabbiani C, Biver T. A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes. J Inorg Biochem 2021;217:111355. [PMID: 33596529 DOI: 10.1016/j.jinorgbio.2021.111355] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
169 Cai DH, Zhang CL, Liu QY, He L, Liu YJ, Xiong YH, Le XY. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate. Eur J Med Chem 2021;213:113182. [PMID: 33486198 DOI: 10.1016/j.ejmech.2021.113182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
170 Gibson D. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end? J Inorg Biochem 2021;217:111353. [PMID: 33477089 DOI: 10.1016/j.jinorgbio.2020.111353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 14.5] [Reference Citation Analysis]
171 Bhattacharyya A, Jameei A, Saha R, Garai A, Karande AA, Chakravarty AR. BODIPY-linked cis -dichlorido zinc( ii ) conjugates: the strategic design of organelle-specific next-generation theranostic photosensitizers. Dalton Trans 2021;50:103-15. [DOI: 10.1039/d0dt03342a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
172 Afroj F. The Medicinal Chemistry of Metal-Containing Anticancer drugs. SSRN Journal. [DOI: 10.2139/ssrn.3859521] [Reference Citation Analysis]
173 Kar B, Das U, De S, Pete S, Sharma S A, Roy N, S K AK, Panda D, Paira P. GSH-resistant and highly cytoselective ruthenium(II)-p-cymene-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agents. Dalton Trans 2021;50:10369-73. [PMID: 34308466 DOI: 10.1039/d1dt01604k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
174 Valente A, Morais TS, Teixeira RG, Matos CP, Tomaz AI, Garcia MH. Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents. Synthetic Inorganic Chemistry 2021. [DOI: 10.1016/b978-0-12-818429-5.00010-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Kumar P, Singh P, Saren S, Pakira S, Sivakumar S, Patra AK. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity. Dalton Trans 2021;50:8196-217. [PMID: 34031678 DOI: 10.1039/d1dt00246e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Zhang Y, Ma Z, Qiao P, Gao C, Tian J, Zhao J, Du W, Xu J, Yan S. Design and biological evaluations of mono- and di-nuclear copper(II) complexes: Nuclease activity, cytotoxicity and apoptosis. Polyhedron 2021;193:114880. [DOI: 10.1016/j.poly.2020.114880] [Reference Citation Analysis]
177 Das B, Gupta P. Luminescent terpyridine appended geminal bisazide and bistriazoles: multinuclear Pt(II) complexes and AIPE-based DNA detection with the naked eye. Dalton Trans 2021;50:10225-36. [PMID: 34236066 DOI: 10.1039/d1dt01108a] [Reference Citation Analysis]
178 Michlewska S, Maroto M, Hołota M, Kubczak M, Sanz Del Olmo N, Ortega P, Shcharbin D, de la Mata FJ, Bryszewska M, Ionov M. Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells. Dalton Trans 2021;50:9500-11. [PMID: 34254615 DOI: 10.1039/d1dt01388b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
179 Timerbaev AR. Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand? J Anal At Spectrom 2021;36:254-66. [DOI: 10.1039/d0ja00404a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
180 Teixeira RG, Belisario DC, Fontrodona X, Romero I, Tomaz AI, Garcia MH, Riganti C, Valente A. Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds. Inorg Chem Front 2021;8:1983-96. [DOI: 10.1039/d0qi01344g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
181 Guimarães IDL, Marszaukowski F, Ribeiro R, de Lazaro SR, de Oliveira KM, Batista AA, Castellen P, Wrobel E, Garcia JR, Boeré RT, Wohnrath K. Synthesis and characterization of η6-p-cymene ruthenium(II) complexes containing alkyl- and methoxy-substituted triarylphosphines. Journal of Organometallic Chemistry 2021;931:121599. [DOI: 10.1016/j.jorganchem.2020.121599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
182 Y. SP, Krishnamoorthy L, Chowdary AS, Chinta JP, Subbiah N. Metals and Metal Complexes for Medicinal Applications. Environmental Chemistry for a Sustainable World 2021. [DOI: 10.1007/978-3-030-56413-1_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
183 Jiang C, Huang H, Kang X, Yang L, Xi Z, Sun H, Pluth MD, Yi L. NBD-based synthetic probes for sensing small molecules and proteins: design, sensing mechanisms and biological applications. Chem Soc Rev 2021;50:7436-95. [PMID: 34075930 DOI: 10.1039/d0cs01096k] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 23.5] [Reference Citation Analysis]
184 Santi M, Mapanao AK, Biancalana L, Marchetti F, Voliani V. Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomas. Eur J Med Chem 2021;212:113143. [PMID: 33445155 DOI: 10.1016/j.ejmech.2020.113143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
185 Muddassir M, Alarifi A, Afzal M. A New Piano-Stool Ruthenium(II) P-Cymene-Based Complex: Crystallographic, Hirshfeld Surface, DFT, and Luminescent Studies. Crystals 2021;11:13. [DOI: 10.3390/cryst11010013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
186 Wernitznig D, Meier-Menches SM, Cseh K, Theiner S, Wenisch D, Schweikert A, Jakupec MA, Koellensperger G, Wernitznig A, Sommergruber W, Keppler BK. Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids. Metallomics 2020;12:2121-33. [PMID: 33295928 DOI: 10.1039/d0mt00227e] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
187 Liu Z, Li Z, Du T, Chen Y, Wang Q, Li G, Liu M, Zhang N, Li D, Han J. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism. Dalton Trans 2021;50:362-75. [PMID: 33319888 DOI: 10.1039/d0dt03194a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
188 Hassoon AA, Szorcsik A, Bogár F, Papp IZ, Fülöp L, Kele Z, Gajda T. The interaction of half-sandwich (η5-Cp*)Rh(III) cation with histidine containing peptides and their ternary species with (N,N) bidentate ligands. J Inorg Biochem 2021;216:111330. [PMID: 33360738 DOI: 10.1016/j.jinorgbio.2020.111330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
189 Ariga K. Nanoarchitectonics Revolution and Evolution: From Small Science to Big Technology. Small Science 2021;1:2000032. [DOI: 10.1002/smsc.202000032] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
190 Han X, Sahihi M, Whitfield S, Jimenez I. Tuning excited state of bipyridyl platinum(II) complexes with bio-active flavonolate ligand: Structures, photoreactivity, and DFT calculations. Inorganica Chimica Acta 2020;513:119952. [DOI: 10.1016/j.ica.2020.119952] [Reference Citation Analysis]
191 Gupta PSS, Bhat HR, Biswal S, Rana MK. Computer-aided discovery of bis-indole derivatives as multi-target drugs against cancer and bacterial infections: DFT, docking, virtual screening, and molecular dynamics studies. Journal of Molecular Liquids 2020;320:114375. [DOI: 10.1016/j.molliq.2020.114375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
192 Sudhindra P, Ajay Sharma S, Roy N, Moharana P, Paira P. Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review. Polyhedron 2020;192:114827. [DOI: 10.1016/j.poly.2020.114827] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
193 Biancalana L, Batchelor LK, Pereira SAP, Tseng P, Zacchini S, Pampaloni G, Saraiva LMFS, Dyson PJ, Marchetti F. Bis‐conjugation of Bioactive Molecules to Cisplatin‐like Complexes through (2,2′‐Bipyridine)‐4,4′‐Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen. Chem Eur J 2020;26:17525-35. [DOI: 10.1002/chem.202003199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
194 Frei A, King AP, Lowe GJ, Cain AK, Short FL, Dinh H, Elliott AG, Zuegg J, Wilson JJ, Blaskovich MAT. Nontoxic Cobalt(III) Schiff Base Complexes with Broad-Spectrum Antifungal Activity. Chemistry 2021;27:2021-9. [PMID: 33231906 DOI: 10.1002/chem.202003545] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
195 Łakomska I, Śmiłowicz D, Jakubowski M, Sitkowski J, Wojtczak A. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents. Materials (Basel) 2020;13:E5312. [PMID: 33255252 DOI: 10.3390/ma13235312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
196 Chen Y, Wang Q, Li Z, Liu Z, Zhao Y, Zhang J, Liu M, Wang Z, Li D, Han J. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo. Dalton Trans 2020;49:5192-204. [PMID: 32236281 DOI: 10.1039/d0dt00424c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
197 Haseloer A, Lützenburg T, Strache JP, Neudörfl J, Neundorf I, Klein A. Building up PtII -Thiosemicarbazone-Lysine-sC18 Conjugates. Chembiochem 2021;22:694-704. [PMID: 32909347 DOI: 10.1002/cbic.202000564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
198 Dai Z, Wang Z. Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action. Molecules 2020;25:E5167. [PMID: 33171980 DOI: 10.3390/molecules25215167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
199 Liu X, Shao M, Liang C, Guo J, Wang G, Yuan XA, Jing Z, Tian L, Liu Z. Preparation and Bioactivity of Iridium(III) Phenanthroline Complexes with Halide Ions and Pyridine Leaving Groups. Chembiochem 2021;22:557-64. [PMID: 32964620 DOI: 10.1002/cbic.202000511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
200 Yin H, Gao J, Chen X, Ma B, Yang Z, Tang J, Wang B, Chen T, Wang C, Gao S, Zhang J. A Gallium(III) Complex that Engages Protein Disulfide Isomerase A3 (PDIA3) as an Anticancer Target. Angew Chem 2020;132:20322-20328. [DOI: 10.1002/ange.202008432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Kaur M, Loveleen, Kumar R. Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes. Bioorg Chem 2020;105:104396. [PMID: 33130345 DOI: 10.1016/j.bioorg.2020.104396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
202 Tyagi N, Singh O, Mishra RK, Ghosh K. Bio-macromolecular interaction studies: Synthesis, crystal structure of water-soluble manganese(II) complexes. Inorganica Chimica Acta 2020;512:119882. [DOI: 10.1016/j.ica.2020.119882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
203 Kar B, Roy N, Pete S, Moharana P, Paira P. Ruthenium and iridium based mononuclear and multinuclear complexes: A Breakthrough of Next-Generation anticancer metallopharmaceuticals. Inorganica Chimica Acta 2020;512:119858. [DOI: 10.1016/j.ica.2020.119858] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
204 Nagy I, Ferenczik G, Bíró L, Farkas E, Cs. Bényei A, Buglyó P. Metal complexation of deferasirox derivatives: A solid state and equilibrium study. Polyhedron 2020;190:114780. [DOI: 10.1016/j.poly.2020.114780] [Reference Citation Analysis]
205 Oliveira KM, Honorato J, Demidoff FC, Schultz MS, Netto CD, Cominetti MR, Correa RS, Batista AA. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug. J Inorg Biochem 2021;214:111289. [PMID: 33137682 DOI: 10.1016/j.jinorgbio.2020.111289] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
206 Claudel M, Schwarte JV, Fromm KM. New Antimicrobial Strategies Based on Metal Complexes. Chemistry 2020;2:849-99. [DOI: 10.3390/chemistry2040056] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 16.3] [Reference Citation Analysis]
207 Maji M, Karmakar S, Ruturaj, Gupta A, Mukherjee A. Oxamusplatin: a cytotoxic Pt(ii) complex of a nitrogen mustard with resistance to thiol based sequestration displays enhanced selectivity towards cancer. Dalton Trans 2020;49:2547-58. [PMID: 32022814 DOI: 10.1039/c9dt04269e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
208 Wang Y, Jin J, Shu L, Li T, Lu S, Subarkhan MKM, Chen C, Wang H. New Organometallic Ruthenium(II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer. Chemistry 2020;26:15170-82. [PMID: 32639591 DOI: 10.1002/chem.202002970] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
209 Ribeiro GH, Guedes APM, de Oliveira TD, de Correia CRSTB, Colina-Vegas L, Lima MA, Nóbrega JA, Cominetti MR, Rocha FV, Ferreira AG, Castellano EE, Teixeira FR, Batista AA. Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction. Inorg Chem 2020;59:15004-18. [PMID: 32997499 DOI: 10.1021/acs.inorgchem.0c01835] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
210 Li C, Jia P, Xu Y, Ding F, Yang W, Sun Y, Li X, Yin G, Xu L, Yang G. Photoacoustic imaging-guided chemo-photothermal combinational therapy based on emissive Pt(II) metallacycle-loaded biomimic melanin dots. Sci China Chem 2021;64:134-42. [DOI: 10.1007/s11426-020-9856-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
211 Alberto ME, Mazzone G, Regina C, Russo N, Sicilia E. Theoretical exploration of the photophysical properties of two-component RuII-porphyrin dyes as promising assemblies for a combined antitumor effect. Dalton Trans 2020;49:12653-61. [PMID: 32870211 DOI: 10.1039/d0dt02197k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
212 Jayawardhana AMDS, Stilgenbauer M, Datta P, Qiu Z, Mckenzie S, Wang H, Bowers D, Kurokawa M, Zheng YR. Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36. Chem Commun (Camb) 2020;56:10706-9. [PMID: 32789350 DOI: 10.1039/d0cc02174a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
213 Ahmedova A, Mihaylova R, Stoykova S, Mihaylova V, Paunova-Krasteva T, Mihaylov L, Stoitsova S, Nihtianova D, Momekov G, Momekova D, Yoshizawa M. Enhanced cellular uptake of platinum by a tetracationic Pt(II) nanocapsule and its implications to cancer treatment. Eur J Pharm Sci 2020;155:105545. [PMID: 32927069 DOI: 10.1016/j.ejps.2020.105545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
214 Srivastava A, Naik RM, Rastogi R. Spectrophotometric kinetic study of mercury(II)-catalyzed formation of [4-CNpyRu(CN)5]3− via ligand exchange reaction of hexacyanoruthenate(II) with 4-cyanopyridine: a mechanistic approach. J IRAN CHEM SOC 2020;17:2327-33. [DOI: 10.1007/s13738-020-01927-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
215 Lai L, Xiong Z, Ma L, Chen T. Smart Microenvironment-Responsive Organocopper(II) Supramolecular Polymers to Regulate the Stability and Anticancer Efficacy by Different Substituents. ACS Appl Mater Interfaces 2020;12:40013-20. [PMID: 32805979 DOI: 10.1021/acsami.0c09919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Yin H, Gao J, Chen X, Ma B, Yang Z, Tang J, Wang B, Chen T, Wang C, Gao S, Zhang J. A Gallium(III) Complex that Engages Protein Disulfide Isomerase A3 (PDIA3) as an Anticancer Target. Angew Chem Int Ed 2020;59:20147-53. [DOI: 10.1002/anie.202008432] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
217 Bouché M, Hognon C, Grandemange S, Monari A, Gros PC. Recent advances in iron-complexes as drug candidates for cancer therapy: reactivity, mechanism of action and metabolites. Dalton Trans 2020;49:11451-66. [PMID: 32776052 DOI: 10.1039/d0dt02135k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
218 Tong KKH, Hanif M, Lovett JH, Hummitzsch K, Harris HH, Söhnel T, Jamieson SMF, Hartinger CG. Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity. Molecules 2020;25:E3661. [PMID: 32796732 DOI: 10.3390/molecules25163661] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
219 Cao Q, Zhou DJ, Pan ZY, Yang GG, Zhang H, Ji LN, Mao ZW. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors. Angew Chem Int Ed Engl 2020;59:18556-62. [PMID: 32557982 DOI: 10.1002/anie.202005362] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 16.3] [Reference Citation Analysis]
220 Cao Q, Zhou D, Pan Z, Yang G, Zhang H, Ji L, Mao Z. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors. Angew Chem 2020;132:18715-21. [DOI: 10.1002/ange.202005362] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
221 Karges J, Chao H, Gasser G. Synthesis, Characterization, and Biological Evaluation of the Polymeric Encapsulation of a Ruthenium(II) Polypyridine Complex with Pluronic F‐127/Poloxamer‐407 for Photodynamic Therapy Applications. Eur J Inorg Chem 2020;2020:3242-8. [DOI: 10.1002/ejic.202000545] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
222 Chen S, Yao H, Zhou Q, Tse MK, Gunawan YF, Zhu G. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues. Inorg Chem 2020;59:11676-87. [PMID: 32799457 DOI: 10.1021/acs.inorgchem.0c01541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
223 Das D, Raza MK, Goswami TK. Evaluation of photochemotherapeutic potential of a few oxo-bridged dimeric Fe(III) compounds having Salen-type ligands. Polyhedron 2020;186:114614. [DOI: 10.1016/j.poly.2020.114614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
224 Florio D, Cuomo M, Iacobucci I, Ferraro G, Mansour AM, Monti M, Merlino A, Marasco D. Modulation of Amyloidogenic Peptide Aggregation by Photoactivatable CO-Releasing Ruthenium(II) Complexes. Pharmaceuticals (Basel) 2020;13:E171. [PMID: 32751396 DOI: 10.3390/ph13080171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
225 Backman-Blanco G, Valdés H, Ramírez-Apan MT, Cano-Sanchez P, Hernandez-Ortega S, Orjuela AL, Alí-Torres J, Flores-Gaspar A, Reyes-Martínez R, Morales-Morales D. Synthesis of Pt(II) complexes of the type [Pt(1,10-phenanthroline)(SArFn)2] (SArFn = SC6H3-3,4-F2; SC6F4-4-H; SC6F5). Preliminary evaluation of their in vitro anticancer activity. J Inorg Biochem 2020;211:111206. [PMID: 32801098 DOI: 10.1016/j.jinorgbio.2020.111206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
226 Malali S, Chyba J, Knor M, Horní M, Nečas M, Novotný J, Marek R. Zwitterionic Ru(III) Complexes: Stability of Metal-Ligand Bond and Host-Guest Binding with Cucurbit[7]uril. Inorg Chem 2020;59:10185-96. [PMID: 32633504 DOI: 10.1021/acs.inorgchem.0c01328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
227 Xiong K, Qian C, Yuan Y, Wei L, Liao X, He L, Rees TW, Chen Y, Wan J, Ji L, Chao H. Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II. Angew Chem Int Ed Engl 2020;59:16631-7. [PMID: 32533618 DOI: 10.1002/anie.202006089] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
228 Xiong K, Qian C, Yuan Y, Wei L, Liao X, He L, Rees TW, Chen Y, Wan J, Ji L, Chao H. Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II. Angew Chem 2020. [DOI: 10.1002/ange.202006089] [Reference Citation Analysis]
229 Jain S, Bhar K, Bandyopadhayaya S, Singh VK, Mandal CC, Tapryal S, Sharma AK. Development, evaluation and effect of anionic co-ligand on the biological activity of benzothiazole derived copper(II) complexes. J Inorg Biochem 2020;210:111174. [PMID: 32652261 DOI: 10.1016/j.jinorgbio.2020.111174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
230 Chen C, Xu C, Li T, Lu S, Luo F, Wang H. Novel NHC-coordinated ruthenium(II) arene complexes achieve synergistic efficacy as safe and effective anticancer therapeutics. Eur J Med Chem 2020;203:112605. [PMID: 32688202 DOI: 10.1016/j.ejmech.2020.112605] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
231 Yi N, Jiang Z, Wang L, Luo P, Peng F. Crystal structure and anti-breast cancer activity evaluation of a nanosized bismuth(V)-containing coordination complex based on the F-decorated ligand. Inorganic and Nano-Metal Chemistry 2020;50:562-8. [DOI: 10.1080/24701556.2020.1722693] [Reference Citation Analysis]
232 Yufanyi DM, Abbo HS, Titinchi SJ, Neville T. Platinum(II) and Ruthenium(II) complexes in medicine: Antimycobacterial and Anti-HIV activities. Coordination Chemistry Reviews 2020;414:213285. [DOI: 10.1016/j.ccr.2020.213285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
233 Maji M, Acharya S, Maji S, Purkait K, Gupta A, Mukherjee A. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand. Inorg Chem 2020;59:10262-74. [PMID: 32585099 DOI: 10.1021/acs.inorgchem.0c01433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
234 Pavlović M, Tadić A, Gligorijević N, Poljarević J, Petrović T, Dojčinović B, Savić A, Radulović S, Grgurić-Šipka S, Aranđelović S. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells. J Inorg Biochem 2020;210:111155. [PMID: 32768729 DOI: 10.1016/j.jinorgbio.2020.111155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
235 Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood. Dalton Trans 2020;49:8107-13. [PMID: 32490446 DOI: 10.1039/d0dt01297a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
236 Varol M, Varol TÖ. The Role of Metals and Metallodrugs in the Modulation of Angiogenesis. Advances in Metallodrugs 2020. [DOI: 10.1002/9781119640868.ch10] [Reference Citation Analysis]
237 Sousa LM, Araújo DMS, Oliveira KM, De Oliveira LP, Maia PIS, Deflon VM, Batista AA, Machado AEH, Guerra W, Von Poelhsitz G. Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands. Journal of Coordination Chemistry 2020;73:1605-18. [DOI: 10.1080/00958972.2020.1777286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Li Y, Yue K, Li L, Niu J, Liu H, Ma J, Xie S. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance. Bioorg Chem 2020;101:104011. [PMID: 32599363 DOI: 10.1016/j.bioorg.2020.104011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
239 Oliveira BL, Stenton BJ, Unnikrishnan VB, de Almeida CR, Conde J, Negrão M, Schneider FSS, Cordeiro C, Ferreira MG, Caramori GF, Domingos JB, Fior R, Bernardes GJL. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation. J Am Chem Soc 2020;142:10869-80. [PMID: 32456416 DOI: 10.1021/jacs.0c01622] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 14.3] [Reference Citation Analysis]
240 Ferraro MG, Piccolo M, Misso G, Maione F, Montesarchio D, Caraglia M, Paduano L, Santamaria R, Irace C. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems. Cells 2020;9:E1412. [PMID: 32517101 DOI: 10.3390/cells9061412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
241 Mandal P, Sonkar C, Dhankhar SS, Nagaraja C, Mukhopadhyay S. Ruthenium(II)-arene complexes containing ferrocenamide ligands: Synthesis, characterisation and antiproliferative activity against cancer cell lines. Journal of Organometallic Chemistry 2020;916:121247. [DOI: 10.1016/j.jorganchem.2020.121247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
242 Gelle D, Lamač M, Mach K, Šimková L, Gyepes R, Sommerová L, Martišová A, Bartošík M, Vaculovič T, Kanický V, Hrstka R, Pinkas J. Enhanced Intracellular Accumulation and Cytotoxicity of Ferrocene‐Ruthenium Arene Conjugates. ChemPlusChem 2020;85:1034-43. [DOI: 10.1002/cplu.202000022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
243 Kitteringham E, Mckeon AM, O'dowd P, Devocelle M, Murphy BM, Griffith DM. Synthesis and characterisation of a novel mono functionalisable Pt(IV) oxaliplatin-type complex and its peptide conjugate. Inorganica Chimica Acta 2020;505:119492. [DOI: 10.1016/j.ica.2020.119492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
244 Li C, Xu F, Zhao Y, Zheng W, Zeng W, Luo Q, Wang Z, Wu K, Du J, Wang F. Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity. Front Chem 2020;8:210. [PMID: 32411653 DOI: 10.3389/fchem.2020.00210] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
245 Liang X, Li L, Tang J, Komiyama M, Ariga K. Dynamism of Supramolecular DNA/RNA Nanoarchitectonics: From Interlocked Structures to Molecular Machines. BCSJ 2020;93:581-603. [DOI: 10.1246/bcsj.20200012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 20.0] [Reference Citation Analysis]
246 Mukherjee A, Acharya S, Purkait K, Chakraborty K, Bhattacharjee A, Mukherjee A. Effect of N,N Coordination and RuII Halide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII (p-Cymene) Complex. Inorg Chem 2020;59:6581-94. [PMID: 32295347 DOI: 10.1021/acs.inorgchem.0c00694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
247 Zhao X, Ji H, Hasrat K, Misal S, He F, Dai Y, Ma F, Qi Z. A mitochondria-targeted single fluorescence probe for separately and continuously visualizing H2S and Cys with multi-response signals. Analytica Chimica Acta 2020;1107:172-82. [DOI: 10.1016/j.aca.2020.02.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
248 Deo KM, Sakoff J, Gilbert J, Zhang Y, Aldrich Wright JR. Synthesis, characterisation and influence of lipophilicity on cellular accumulation and cytotoxicity of unconventional platinum(iv) prodrugs as potent anticancer agents. Dalton Trans 2019;48:17228-40. [PMID: 31728483 DOI: 10.1039/c9dt04049h] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
249 Marković K, Milačič R, Marković S, Kladnik J, Turel I, Ščančar J. Binding Kinetics of Ruthenium Pyrithione Chemotherapeutic Candidates to Human Serum Proteins Studied by HPLC-ICP-MS. Molecules 2020;25:E1512. [PMID: 32225069 DOI: 10.3390/molecules25071512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
250 Babu T, Sarkar A, Karmakar S, Schmidt C, Gibson D. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules. Inorg Chem 2020;59:5182-93. [PMID: 32207294 DOI: 10.1021/acs.inorgchem.0c00445] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
251 Khoury A, Deo KM, Aldrich-Wright JR. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. J Inorg Biochem 2020;207:111070. [PMID: 32299045 DOI: 10.1016/j.jinorgbio.2020.111070] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
252 Ma J, Li L, Yue K, Li Y, Liu H, Wang PG, Wang C, Wang J, Luo W, Xie S. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance. Bioorg Chem 2020;99:103768. [PMID: 32217375 DOI: 10.1016/j.bioorg.2020.103768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
253 Liu Y, Miller JJ. Platinum‐Based Anticancer Drugs. Encyclopedia of Inorganic and Bioinorganic Chemistry 2020. [DOI: 10.1002/9781119951438.eibc0178.pub2] [Reference Citation Analysis]
254 Annunziata A, Amoresano A, Cucciolito ME, Esposito R, Ferraro G, Iacobucci I, Imbimbo P, Lucignano R, Melchiorre M, Monti M, Scognamiglio C, Tuzi A, Monti DM, Merlino A, Ruffo F. Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes. Inorg Chem 2020;59:4002-14. [PMID: 32129608 DOI: 10.1021/acs.inorgchem.9b03683] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
255 Purkait K, Mukherjee A. Cytotoxicity and reactivity of a redox active 1,4-quinone-pyrazole compound and its Ru(II)-p-cymene complex. Inorganica Chimica Acta 2020;502:119361. [DOI: 10.1016/j.ica.2019.119361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
256 Frei A. Metal Complexes, an Untapped Source of Antibiotic Potential? Antibiotics (Basel) 2020;9:E90. [PMID: 32085590 DOI: 10.3390/antibiotics9020090] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 21.7] [Reference Citation Analysis]
257 Frei A, Zuegg J, Elliott AG, Baker M, Braese S, Brown C, Chen F, G Dowson C, Dujardin G, Jung N, King AP, Mansour AM, Massi M, Moat J, Mohamed HA, Renfrew AK, Rutledge PJ, Sadler PJ, Todd MH, Willans CE, Wilson JJ, Cooper MA, Blaskovich MAT. Metal complexes as a promising source for new antibiotics. Chem Sci 2020;11:2627-39. [PMID: 32206266 DOI: 10.1039/c9sc06460e] [Cited by in Crossref: 165] [Cited by in F6Publishing: 171] [Article Influence: 55.0] [Reference Citation Analysis]
258 Seroka B, Łotowski Z, Hryniewicka A, Rárová L, R Sicinski R, M Tomkiel A, W Morzycki J. Synthesis of New Cisplatin Derivatives from Bile Acids. Molecules 2020;25:E655. [PMID: 32033039 DOI: 10.3390/molecules25030655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
259 Lázaro A, Balcells C, Quirante J, Badia J, Baldomà L, Ward JS, Rissanen K, Font-Bardia M, Rodríguez L, Crespo M, Cascante M. Luminescent PtII and PtIV Platinacycles with Anticancer Activity Against Multiplatinum-Resistant Metastatic CRC and CRPC Cell Models. Chemistry 2020;26:1947-52. [PMID: 31909511 DOI: 10.1002/chem.201905325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
260 Tang L, Cai D, Qin M, Lu S, Hu MH, Ruan S, Jin G, Wang Z. Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy. ACS Omega 2020;5:726-34. [PMID: 31956823 DOI: 10.1021/acsomega.9b03381] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
261 Sharma KS, Dubey AK, Koijam AS, Kumar C, Ballal A, Mukherjee S, Phadnis PP, Vatsa RK. Synthesis of 2-deoxy-d-glucose coated Fe3O4 nanoparticles for application in targeted delivery of the Pt(iv) prodrug of cisplatin – a novel approach in chemotherapy. New J Chem 2020;44:13863-13874. [DOI: 10.1039/c9nj05989j] [Reference Citation Analysis]
262 Khan TA, Bhar K, Thirumoorthi R, Roy TK, Sharma AK. Design, synthesis, characterization and evaluation of the anticancer activity of water-soluble half-sandwich ruthenium( ii ) arene halido complexes. New J Chem 2020;44:239-57. [DOI: 10.1039/c9nj03663f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
263 Yuan S, Chen S, Wu H, Jiang H, Zheng S, Zhang Q, Liu Y. NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug. Chem Commun 2020;56:1397-400. [DOI: 10.1039/c9cc08775c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
264 Liu M, Song X, Wu Y, Qian J, Xu J. Cu( ii )-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis. Dalton Trans 2020;49:114-23. [DOI: 10.1039/c9dt03641e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
265 Zhao Y, Kang Y, Xu F, Zheng W, Luo Q, Zhang Y, Jia F, Wang F. Pharmacophore conjugation strategy for multi-targeting metal-based anticancer complexes. Medicinal Chemistry 2020. [DOI: 10.1016/bs.adioch.2019.10.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
266 Xie L, Guan R, Rees TW, Chao H. Organelle-targeting metal anticancer agents. Medicinal Chemistry. Elsevier; 2020. pp. 287-337. [DOI: 10.1016/bs.adioch.2019.10.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
267 Mondal A, Paira P. Hypoxia efficient and glutathione-resistant cytoselective ruthenium( ii )- p -cymene-arylimidazophenanthroline complexes: biomolecular interaction and live cell imaging. Dalton Trans 2020;49:12865-78. [DOI: 10.1039/d0dt02069a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
268 Hanif M, Hartinger CG. From the hypothesis-driven development of organometallic anticancer drugs to new methods in mode of action studies. Medicinal Chemistry 2020. [DOI: 10.1016/bs.adioch.2019.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
269 Zhang S, Zhong X, Yuan H, Guo Y, Song D, Qi F, Zhu Z, Wang X, Guo Z. Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum( iv ) prodrugs. Chem Sci 2020;11:3829-35. [DOI: 10.1039/d0sc00197j] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
270 Smokrović K, Đilović I, Matković-čalogović D. The affinity of copper(ii) ions towards l-amino acids in the solid-state: a simple route towards mixed complexes. CrystEngComm 2020;22:4963-4968. [DOI: 10.1039/d0ce00687d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
271 Giri B, Kumbhakar S, Selvan K K, Muley A, Maji S. Ruthenium nitrosyl complexes with the molecular framework [Ru II (dmdptz)(bpy)(NO)] n+ (dmdptz: N , N -dimethyl-4,6-di(pyridin-2-yl)-1,3,5-triazin-2-amine and bpy: 2,2′-bipyridine). Electronic structure, reactivity aspects, photorelease, and scavenging of NO. New J Chem 2020;44:18732-44. [DOI: 10.1039/d0nj03923c] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
272 Wang X, Liu X, Wang W, Yang H. Construction of Well-Defined Discrete Metallacycles and Their Biological Applications. Handbook of Macrocyclic Supramolecular Assembly 2020. [DOI: 10.1007/978-981-15-2686-2_43] [Reference Citation Analysis]
273 Zhang S, Wang X, Guo Z. Rational design of anticancer platinum(IV) prodrugs. Medicinal Chemistry. Elsevier; 2020. pp. 149-82. [DOI: 10.1016/bs.adioch.2019.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
274 Zhang C, Guan R, Liao X, Ouyang C, Liu J, Ji L, Chao H. Mitochondrial DNA targeting and impairment by a dinuclear Ir–Pt complex that overcomes cisplatin resistance. Inorg Chem Front 2020;7:1864-71. [DOI: 10.1039/d0qi00224k] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
275 Srivastava P, Shukla M, Kaul G, Chopra S, Patra AK. Rationally designed curcumin based ruthenium(ii) antimicrobials effective against drug-resistant Staphylococcus aureus. Dalton Trans 2019;48:11822-8. [PMID: 31215556 DOI: 10.1039/c9dt01650c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
276 Karmakar S, Chatterjee S, Purkait K, Mukherjee A. A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studies. J Inorg Biochem 2020;204:110982. [PMID: 31911365 DOI: 10.1016/j.jinorgbio.2019.110982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
277 Zhang WY, Banerjee S, Imberti C, Clarkson GJ, Wang Q, Zhong Q, Young LS, Romero-Canelón I, Zeng M, Habtemariam A, Sadler PJ. Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry. Inorganica Chim Acta 2020;503:119396. [PMID: 33776131 DOI: 10.1016/j.ica.2019.119396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
278 Liu H, Ma J, Li Y, Yue K, Li L, Xi Z, Zhang X, Liu J, Feng K, Ma Q, Liu S, Guo S, Wang PG, Wang C, Xie S. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents. J Med Chem 2019;62:11324-34. [PMID: 31765154 DOI: 10.1021/acs.jmedchem.9b01641] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
279 Murray BS, Dyson PJ. Recent progress in the development of organometallics for the treatment of cancer. Curr Opin Chem Biol 2020;56:28-34. [PMID: 31812831 DOI: 10.1016/j.cbpa.2019.11.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
280 Rocco D, Batchelor LK, Ferretti E, Zacchini S, Pampaloni G, Dyson PJ, Marchetti F. Piano Stool Aminoalkylidene‐Ferracyclopentenone Complexes from Bimetallic Precursors: Synthesis and Cytotoxicity Data. ChemPlusChem 2020;85:110-22. [DOI: 10.1002/cplu.201900639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
281 Jain A. Multifunctional, heterometallic ruthenium-platinum complexes with medicinal applications. Coordination Chemistry Reviews 2019;401:213067. [DOI: 10.1016/j.ccr.2019.213067] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
282 Cuccioloni M, Bonfili L, Cecarini V, Nabissi M, Pettinari R, Marchetti F, Petrelli R, Cappellacci L, Angeletti M, Eleuteri AM. Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget-Directed Hydrazone Ruthenium(II)-Arene Complexes. ChemMedChem 2020;15:105-13. [PMID: 31701643 DOI: 10.1002/cmdc.201900551] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
283 Liu Y, Tian H, Xu L, Zhou L, Wang J, Xu B, Liu C, Elding LI, Shi T. Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma. Int J Mol Sci 2019;20:E5660. [PMID: 31726728 DOI: 10.3390/ijms20225660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
284 Boros E, Dyson PJ, Gasser G. Classification of Metal-based Drugs According to Their Mechanisms of Action. Chem 2020;6:41-60. [PMID: 32864503 DOI: 10.1016/j.chempr.2019.10.013] [Cited by in Crossref: 126] [Cited by in F6Publishing: 135] [Article Influence: 31.5] [Reference Citation Analysis]
285 Zhang Z, Yu P, Gou Y, Zhang J, Li S, Cai M, Sun H, Yang F, Liang H. Novel Brain-Tumor-Inhibiting Copper(II) Compound Based on a Human Serum Albumin (HSA)-Cell Penetrating Peptide Conjugate. J Med Chem 2019;62:10630-44. [DOI: 10.1021/acs.jmedchem.9b00939] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
286 Jiang W, Fan S, Zhou Q, Zhang F, Kuang D, Tan Y. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties. Bioorg Chem 2020;94:103402. [PMID: 31718891 DOI: 10.1016/j.bioorg.2019.103402] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
287 Saha S, Peña B, Dunbar KR. Partially Solvated Dinuclear Ruthenium Compounds Bridged by Quinoxaline-Functionalized Ligands as Ru(II) Photocage Architectures for Low-Energy Light Absorption. Inorg Chem 2019;58:14568-76. [PMID: 31647230 DOI: 10.1021/acs.inorgchem.9b02232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
288 Biancalana L, Gruchała M, Batchelor LK, Błauż A, Monti A, Pampaloni G, Rychlik B, Dyson PJ, Marchetti F. Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization. Eur J Inorg Chem 2020;2020:1061-72. [DOI: 10.1002/ejic.201900922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
289 Yempala T, Babu T, Karmakar S, Nemirovski A, Ishan M, Gandin V, Gibson D. Expanding the Arsenal of PtIV Anticancer Agents: Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group. Angew Chem Int Ed Engl 2019;58:18218-23. [PMID: 31599054 DOI: 10.1002/anie.201910014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
290 Yempala T, Babu T, Karmakar S, Nemirovski A, Ishan M, Gandin V, Gibson D. Expanding the Arsenal of Pt IV Anticancer Agents: Multi‐action Pt IV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group. Angew Chem 2019;131:18386-91. [DOI: 10.1002/ange.201910014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
291 Purkait K, Ruturaj, Mukherjee A, Gupta A. ATP7B Binds Ruthenium(II) p-Cymene Half-Sandwich Complexes: Role of Steric Hindrance and Ru-I Coordination in Rescuing the Sequestration. Inorg Chem 2019;58:15659-70. [PMID: 31657924 DOI: 10.1021/acs.inorgchem.9b02780] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
292 Barrett S, De Franco M, Kellett A, Dempsey E, Marzano C, Erxleben A, Gandin V, Montagner D. Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes. J Biol Inorg Chem 2020;25:49-60. [DOI: 10.1007/s00775-019-01732-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
293 Rehm T, Rothemund M, Dietel T, Kempe R, Schobert R. Synthesis, structures and cytotoxic effects in vitro of cis- and trans-[PtIVCl4(NHC)2] complexes and their PtII precursors. Dalton Trans 2019;48:16358-65. [PMID: 31624819 DOI: 10.1039/c9dt02438g] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
294 Askari B, Amiri Rudbari H, Micale N, Schirmeister T, Efferth T, Seo EJ, Bruno G, Schwickert K. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies. Dalton Trans 2019;48:15869-87. [PMID: 31620752 DOI: 10.1039/c9dt02353d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
295 Kladnik J, Kljun J, Burmeister H, Ott I, Romero-Canelón I, Turel I. Towards Identification of Essential Structural Elements of Organoruthenium(II)-Pyrithionato Complexes for Anticancer Activity. Chemistry 2019;25:14169-82. [PMID: 31461189 DOI: 10.1002/chem.201903109] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
296 Annunziata A, Cucciolito ME, Esposito R, Ferraro G, Monti DM, Merlino A, Ruffo F. Five‐Coordinate Platinum(II) Compounds as Potential Anticancer Agents. Eur J Inorg Chem 2020;2020:918-29. [DOI: 10.1002/ejic.201900771] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
297 Tremlett WD, Tong KK, Steel TR, Movassaghi S, Hanif M, Jamieson SM, Söhnel T, Hartinger CG. Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubility. Journal of Inorganic Biochemistry 2019;199:110768. [DOI: 10.1016/j.jinorgbio.2019.110768] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
298 Kaneko M, Kato A, Nakashima S, Kitatsuji Y. Density Functional Theory (DFT)-Based Bonding Analysis Correlates Ligand Field Strength with 99 Ru Mössbauer Parameters of Ruthenium–Nitrosyl Complexes. Inorg Chem 2019;58:14024-33. [DOI: 10.1021/acs.inorgchem.9b02024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
299 Sánchez-mora A, Valdés H, Ramírez-apan MT, Nieto-camacho A, Hernández-ortega S, Canseco-gonzález D, Morales-morales D. NHC-Ir(I) complexes derived from 5,6-dinitrobenzimidazole. Synthesis, characterization and preliminary evaluation of their in vitro anticancer activity. Inorganica Chimica Acta 2019;496:119061. [DOI: 10.1016/j.ica.2019.119061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
300 Kumar P, Swagatika S, Dasari S, Tomar RS, Patra AK. Modulation of ruthenium anticancer drugs analogs with tolfenamic acid: Reactivity, biological interactions and growth inhibition of yeast cell. Journal of Inorganic Biochemistry 2019;199:110769. [DOI: 10.1016/j.jinorgbio.2019.110769] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
301 Yu H, Tan Y, Kuang D, Zhang F, Jiang W. Synthesis, structure and biological activity of diphenyltin complexes based on O,N,O-tridentate ligands. Inorganica Chimica Acta 2019;496:119044. [DOI: 10.1016/j.ica.2019.119044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
302 Mármol I, Castellnou P, Alvarez R, Gimeno MC, Rodríguez-Yoldi MJ, Cerrada E. Alkynyl Gold(I) complexes derived from 3-hydroxyflavones as multi-targeted drugs against colon cancer. Eur J Med Chem 2019;183:111661. [PMID: 31546196 DOI: 10.1016/j.ejmech.2019.111661] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
303 Štarha P, Trávníček Z. Non-platinum complexes containing releasable biologically active ligands. Coordination Chemistry Reviews 2019;395:130-45. [DOI: 10.1016/j.ccr.2019.06.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 13.5] [Reference Citation Analysis]
304 Okulova Y, Zenin I, Shutkov I, Kirsanov K, Kovaleva O, Lesovaya E, Fetisov T, Milaeva E, Nazarov A. Antiproliferative activity of Pt(IV) complexes with lonidamine and bexarotene ligands attached via succinate-ethylenediamine linker. Inorganica Chimica Acta 2019;495:119010. [DOI: 10.1016/j.ica.2019.119010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
305 Kitteringham E, Andriollo E, Gandin V, Montagner D, Griffith DM. Synthesis, characterisation and in vitro antitumour potential of novel Pt(II) estrogen linked complexes. Inorganica Chimica Acta 2019;495:118944. [DOI: 10.1016/j.ica.2019.05.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
306 Huang H, Cao K, Kong Y, Yuan S, Liu H, Wang Y, Liu Y. A dual functional ruthenium arene complex induces differentiation and apoptosis of acute promyelocytic leukemia cells. Chem Sci 2019;10:9721-8. [PMID: 32055340 DOI: 10.1039/c9sc03110c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
307 Michlewska S, Kubczak M, Maroto-Díaz M, Sanz Del Olmo N, Ortega P, Shcharbin D, Gomez Ramirez R, Javier de la Mata F, Ionov M, Bryszewska M. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug. Biomolecules 2019;9:E411. [PMID: 31450702 DOI: 10.3390/biom9090411] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
308 Das D, Banaspati A, Das N, Bora B, Raza MK, Goswami TK. Visible light-induced cytotoxicity studies on Co(ii) complexes having an anthracene-based curcuminoid ligand. Dalton Trans 2019;48:12933-42. [PMID: 31393480 DOI: 10.1039/c9dt01576k] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
309 Demoro B, Bento-Oliveira A, Marques F, Costa Pessoa J, Otero L, Gambino D, F M de Almeida R, Tomaz AI. Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity. Molecules 2019;24:E2861. [PMID: 31394747 DOI: 10.3390/molecules24162861] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
310 Jiang W, Zhou Q, Liu M, Zhang F, Kuang D, Tan Y. Microwave assisted synthesis of disubstituted benzyltin arylformylhydrazone complexes: anticancer activity and DNA‐binding properties. Appl Organometal Chem 2019. [DOI: 10.1002/aoc.5092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
311 Contel M. Unconventional Anticancer Metallodrugs and Strategies to Improve Their Pharmacological Profile. Inorganics 2019;7:88. [DOI: 10.3390/inorganics7070088] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
312 Ramu V, Gautam S, Kondaiah P, Chakravarty AR. Diplatinum(II) Catecholate of Photoactive Boron-Dipyrromethene for Lysosome-Targeted Photodynamic Therapy in Red Light. Inorg Chem 2019;58:9067-75. [PMID: 31268715 DOI: 10.1021/acs.inorgchem.9b00567] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
313 Wang F, Feng H, Liu R, Huang K, Liu Y, Liang H. Synthesis, characterization and antitumor activity of novel gold (III) compounds with cisplatin-like structure. Inorganic Chemistry Communications 2019;105:55-58. [DOI: 10.1016/j.inoche.2019.04.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
314 Singh K, Jana A, Lippmann P, Ott I, Das N. Isomeric platinum organometallics derived from pyrimidine, pyridazine or pyrazine and their potential as antitumor drugs. Inorganica Chimica Acta 2019;493:112-7. [DOI: 10.1016/j.ica.2019.04.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
315 Ravera M, Zanellato I, Gabano E, Perin E, Rangone B, Coppola M, Osella D. Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen . Int J Mol Sci 2019;20:E3074. [PMID: 31238499 DOI: 10.3390/ijms20123074] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
316 Ravera M, Gabano E, Mcglinchey MJ, Osella D. A view on multi-action Pt(IV) antitumor prodrugs. Inorganica Chimica Acta 2019;492:32-47. [DOI: 10.1016/j.ica.2019.04.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 12.0] [Reference Citation Analysis]
317 Alessio E, Messori L. NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry. Molecules 2019;24:E1995. [PMID: 31137659 DOI: 10.3390/molecules24101995] [Cited by in Crossref: 161] [Cited by in F6Publishing: 163] [Article Influence: 40.3] [Reference Citation Analysis]
318 Tamasi G, Bonechi C, Donati A, Leone G, Consumi M, Messori L, Magnani A, Cini R, Rossi C. Reactivity of CORM [RuII(CO)3Cl2{N-(N1-methylbenzimidazole)}] with aminoacids. Synthesis, and analytical and structural study for the new binuclear cis-[RuI(CO)2(N-MBI)(μ2-O,O-BAL)]2 sawhorse complex at solid state and in solution. Journal of Molecular Structure 2019;1184:479-486. [DOI: 10.1016/j.molstruc.2019.02.051] [Reference Citation Analysis]
319 Swaminathan S, Haribabu J, Kalagatur NK, Konakanchi R, Balakrishnan N, Bhuvanesh N, Karvembu R. Synthesis and Anticancer Activity of [RuCl26-arene)(aroylthiourea)] Complexes-High Activity against the Human Neuroblastoma (IMR-32) Cancer Cell Line. ACS Omega 2019;4:6245-56. [PMID: 31459766 DOI: 10.1021/acsomega.9b00349] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
320 Zhang R, Song XQ, Liu RP, Ma ZY, Xu JY. Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. J Med Chem 2019;62:4543-54. [PMID: 31002510 DOI: 10.1021/acs.jmedchem.9b00128] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
321 Wang X, Liu X, Wang W, Yang H. Construction of Well-Defined Discrete Metallacycles and Their Biological Applications. Handbook of Macrocyclic Supramolecular Assembly 2019. [DOI: 10.1007/978-981-13-1744-6_43-1] [Reference Citation Analysis]
322 Ude Z, Kavanagh K, Twamley B, Pour M, Gathergood N, Kellett A, Marmion CJ. A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties. Dalton Trans 2019;48:8578-93. [DOI: 10.1039/c9dt00250b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
323 Annunziata A, Cucciolito ME, Esposito R, Imbimbo P, Petruk G, Ferraro G, Pinto V, Tuzi A, Monti DM, Merlino A, Ruffo F. A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum( ii ) complex. Dalton Trans 2019;48:7794-800. [DOI: 10.1039/c9dt01614g] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]